Log In
Print
BCIQ
Print
Print this Print this
 

ChronVac-C

  Manage Alerts
Collapse Summary General Information
Company ChronTech Pharma AB
DescriptionDNA vaccine against HCV delivered using the Medpulser electroporation platform
Molecular Target HCV NS3/4A protease complex
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic HCV genotype 1 infection in treatment-naive patients
Regulatory Designation

Partner

Inovio Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today